Costs associated with cardiovascular events in patients with hypertension in US managed care settings

Mei Sheng Duh1, Nicole M Fulcher, Leigh Ann White

  • 1Analysis Group, Inc., Boston, Massachusetts, USA.

Insights

Cardiovascular events significantly increase healthcare costs for hypertensive patients, especially those with high-risk conditions. Acute myocardial infarction and heart failure incur the highest incremental costs, primarily driven by inpatient services.

Area of Science:

  • Health Economics
  • Cardiovascular Medicine
  • Hypertension Management

Background:

  • Hypertension (HTN) is a prevalent condition often coexisting with high-risk factors.
  • Cardiovascular (CV) events represent significant complications of uncontrolled hypertension.
  • Understanding the economic burden of CV events in specific patient subgroups is crucial for resource allocation.

Purpose of the Study:

  • To quantify the incremental healthcare costs associated with cardiovascular events in high-risk and compelling indication subgroups of hypertensive patients.
  • To compare costs between hypertensive patients with and without CV events, and before and after CV events.

Main Methods:

  • Retrospective analysis of claims data from privately insured individuals diagnosed with hypertension between 2004 and 2006.
  • Regression-adjusted per-member-per-month healthcare costs were estimated post-cardiovascular event (CVE).
  • Costs were analyzed across inpatient, outpatient, and prescription drug components for various CV events.

Main Results:

  • Healthcare costs were significantly higher across all components for hypertensive patients experiencing CV events compared to controls.
  • Acute myocardial infarction (MI) and congestive heart failure (CHF) demonstrated the largest incremental total healthcare costs.
  • Inpatient costs constituted the primary driver of healthcare expenditures in the first quarter following a CV event.

Conclusions:

  • Cardiovascular events are expensive complications of hypertension, particularly in high-risk populations.
  • The findings highlight the substantial economic impact of managing CV events in patients with conditions like diabetes, chronic kidney disease, and prior stroke.
  • Effective hypertension management and prevention of CV events are essential to mitigate significant healthcare expenditures.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...